middle.news
How Will Proteomics International Turn $6M Loss into Diagnostic Growth?
9:10am on Wednesday 25th of February, 2026 AEDT
•
Healthcare
Read Story
How Will Proteomics International Turn $6M Loss into Diagnostic Growth?
9:10am on Wednesday 25th of February, 2026 AEDT
Key Points
Controlled market launches of Promarker D and Promarker Eso in Australia
US CMS reimbursement pricing established for Promarker D effective January 2026
Expansion of regulated laboratory capabilities in Australia and the US
Strengthened intellectual property with new US and Canadian patents
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
PROTEOMICS INTERNATIONAL LABORATORIES (ASX:PIQ)
OPEN ARTICLE